Exelixis
EXEL
#1316
Rank
A$25.09 B
Marketcap
A$102.84
Share price
2.06%
Change (1 day)
61.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total assets

Total assets on the balance sheet as of September 2026 : A$3.64 Billion

According to Exelixis's latest financial reports the company's total assets are A$3.64 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exelixis - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$4.31 B-4.32%
2022-12-31A$4.51 B25.07%
2021-12-31A$3.60 B29.83%
2020-12-31A$2.77 B3.21%
2019-12-31A$2.69 B33.4%
2018-12-31A$2.01 B140.53%
2017-12-31A$0.83 B1.56%
2016-12-31A$0.82 B81.16%
2015-12-31A$0.45 B15.49%
2014-12-31A$0.39 B-29.99%
2013-12-31A$0.56 B-18.69%
2012-12-31A$0.69 B80.92%
2011-12-31A$0.38 B7.98%
2010-12-31A$0.35 B-7.09%
2009-12-31A$0.38 B-32.85%
2008-12-31A$0.56 B20.76%
2007-12-31A$0.47 B-6.03%
2006-12-31A$0.50 B10.31%
2005-12-31A$0.45 B20.78%
2004-12-31A$0.37 B-21.79%
2003-12-31A$0.48 B-20.03%
2002-12-31A$0.60 B-11.38%
2001-12-31A$0.67 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$285.95 B 7,754.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$291.31 B 7,902.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$138.52 B 3,705.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$213.34 B 5,760.38%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$188.00 B 5,064.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$128.57 B 3,431.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$137.74 B 3,683.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
A$27.47 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
A$0.14 B-95.97%๐Ÿ‡บ๐Ÿ‡ธ USA